M Margaret Juliana Selected Research

M Margaret Juliana Research Topics

Disease

20	Neoplasms (Cancer) 01/2020 - 02/2004
14	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2004
9	Carcinogenesis 03/2015 - 04/2006
8	Urinary Bladder Neoplasms (Bladder Cancer) 09/2017 - 03/2005
7	Body Weight (Weight, Body) 09/2017 - 04/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2014 - 02/2010
2	Carcinoma (Carcinomatosis) 02/2009 - 11/2008
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 09/2017
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2017
1	Intestinal Neoplasms (Intestinal Cancer) 07/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2016
1	Actinic Keratosis 08/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2013
1	Colonic Neoplasms (Colon Cancer) 05/2012
1	Neoplasm Metastasis (Metastasis) 02/2010
1	Skin Neoplasms (Skin Cancer) 11/2009
1	Aberrant Crypt Foci 11/2009
1	Adenoma (Adenomas) 11/2009
1	Hyperplasia 07/2006
1	Papilloma (Papillomatosis) 07/2006

Drug/Important Bio-Agent (IBA)

12	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2020 - 02/2005
6	hydroxide ionIBA 04/2015 - 03/2005
5	Bexarotene (LGD1069)FDA Link 01/2020 - 02/2005
4	Gefitinib (Iressa)FDA Link 01/2020 - 04/2008
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2008
4	Naproxen (Naprosyn)FDA LinkGeneric 01/2020 - 11/2009
4	Estrogen ReceptorsIBA 01/2020 - 09/2007
4	NitrosaminesIBA 09/2017 - 11/2008
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 03/2015
3	Glycoproteins (Glycoprotein)IBA 08/2014 - 07/2006
3	OsteopontinIBA 08/2014 - 07/2006
3	Proteins (Proteins, Gene)FDA Link 05/2011 - 07/2006
2	vorozoleIBA 01/2020 - 04/2008
2	Atorvastatin (Lipitor)FDA Link 01/2020 - 02/2009
2	Tamoxifen FDA LinkGeneric 01/2020 - 02/2009
2	Insulin (Novolin)FDA Link 09/2017 - 03/2015
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2015 - 11/2009
2	ErbB Receptors (EGF Receptor)IBA 05/2013 - 04/2008
2	AzoxymethaneIBA 05/2012 - 11/2009
2	CarcinogensIBA 09/2011 - 03/2005
1	Pharmaceutical PreparationsIBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	benz(a)anthracene (benzanthracene)IBA 07/2016
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 07/2016
1	TriterpenesIBA 07/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2015
1	Proton Pump InhibitorsIBA 04/2015
1	Omeprazole (Prilosec)FDA LinkGeneric 04/2015
1	BiguanidesIBA 03/2015
1	AMP-Activated Protein KinasesIBA 03/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2013
1	3,3'-diindolylmethane (diindolylmethane)IBA 09/2011
1	indole-3-carbinolIBA 09/2011
1	beta-NaphthoflavoneIBA 09/2011
1	9,10-Dimethyl-1,2-benzanthraceneIBA 09/2011
1	FlavonoidsIBA 09/2011
1	Annexin A2 (Annexin II)IBA 05/2011
1	NucleolinIBA 05/2011
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2010
1	ResveratrolIBA 04/2010
1	AgarIBA 02/2010
1	naproxen-n-butyl nitrateIBA 11/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2009
1	Lovastatin (Mevacor)FDA LinkGeneric 02/2009
1	Retinoid X Receptors (Retinoid X Receptor)IBA 02/2009
1	PPAR gammaIBA 11/2008
1	Rosiglitazone (Avandia)FDA Link 11/2008
1	PPAR-gamma AgonistsIBA 11/2008
1	Dihydrotachysterol (AT 10)IBA 04/2008
1	TeaIBA 07/2007
1	PolyphenolsIBA 07/2007
1	polyphenon EIBA 07/2007
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 07/2006
1	Bromodeoxyuridine (BrdU)IBA 07/2006
1	tipifarnib (R115777)IBA 04/2006
1	TransferasesIBA 04/2006
1	Apoptosis Regulatory ProteinsIBA 03/2005
1	SurvivinIBA 03/2005
1	Indomethacin (Indometacin)FDA LinkGeneric 03/2005
1	Alitretinoin FDA Link 02/2004
1	RetinoidsIBA 02/2004
1	retinamideIBA 02/2004
1	FenretinideIBA 02/2004

Therapy/Procedure

4	Therapeutics 05/2013 - 02/2005
1	Chemoprevention 04/2015